Young women who were vaccinated against human papillomavirus (HPV) in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked to the virus, a long-running English study found.
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs
When the vaccinated women were in their 20s, those who had received the series of shots between ages 12 and 13 had cervical cancer rates that were 87% lower than unvaccinated women who had been screened for the malignancy. The findings "should greatly reassure those still hesitant about the benefits of HPV vaccination," the researchers said.
The young women who were vaccinated had around 450 fewer cases of cervical cancers and 17,200 fewer cases of CIN3 than expected in unvaccinated women of the same age.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer shares jump 2.5% premarket as earnings beat, company raises guidancePfizer Inc. shares undefined jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance,...
続きを読む »
Suffering From Joint Pain? A New Study Suggests Virtual Fitness Classes Can Improve Pain in Older AdultsRemote Fitness Classes Can Improve Pain in Older Adults, New Study Suggests
続きを読む »
Johnson & Johnson's Covid-19 vaccine is 73.6% effective, according to new real-world studyData from a real-world study assessing Johnson & Johnson's Covid-19 vaccine finds it is 73.6% effective, according to new research
続きを読む »
How To Combat Reverse Ageism At WorkA recent American Psychological Association study revealed that younger adults (ages 15-29) currently experience more age discrimination than older individuals.
続きを読む »
‘Hot Jupiter’ Planet Study May Help Us Find Life-Friendly WorldsYou can think of this study as a practice round for looking at small planet atmospheres.
続きを読む »